Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Delirium due to intoxication from the novel synthetic tryptamine 5-MeO-DALT.

Jovel A, Felthous A, Bhattacharyya A.

J Forensic Sci. 2014 May;59(3):844-6. doi: 10.1111/1556-4029.12367. Epub 2013 Dec 13.

PMID:
24329118
2.

Metabolism of the new psychoactive substances N,N-diallyltryptamine (DALT) and 5-methoxy-DALT and their detectability in urine by GC-MS, LC-MSn, and LC-HR-MS-MS.

Michely JA, Helfer AG, Brandt SD, Meyer MR, Maurer HH.

Anal Bioanal Chem. 2015 Oct;407(25):7831-42. doi: 10.1007/s00216-015-8955-0. Epub 2015 Aug 22.

PMID:
26297461
3.

5-MeO-DALT; a novel designer drug on the market causing acute delirium and rhabdomyolysis.

Kalasho A, Vibe Nielsen S.

Acta Anaesthesiol Scand. 2016 Oct;60(9):1332-6. doi: 10.1111/aas.12765. Epub 2016 Jul 25. No abstract available.

PMID:
27453155
4.

Analytical characterization of N,N-diallyltryptamine (DALT) and 16 ring-substituted derivatives.

Brandt SD, Kavanagh PV, Dowling G, Talbot B, Westphal F, Meyer MR, Maurer HH, Halberstadt AL.

Drug Test Anal. 2017 Jan;9(1):115-126. doi: 10.1002/dta.1974. Epub 2016 Apr 21.

PMID:
27100373
5.

Receptor binding profiles and quantitative structure-affinity relationships of some 5-substituted-N,N-diallyltryptamines.

Cozzi NV, Daley PF.

Bioorg Med Chem Lett. 2016 Feb 1;26(3):959-964. doi: 10.1016/j.bmcl.2015.12.053. Epub 2015 Dec 18.

PMID:
26739781
6.

The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): a brief review.

Corkery JM, Durkin E, Elliott S, Schifano F, Ghodse AH.

Prog Neuropsychopharmacol Biol Psychiatry. 2012 Dec 3;39(2):259-62. doi: 10.1016/j.pnpbp.2012.05.022. Epub 2012 Jun 7. Review.

PMID:
22683457
7.

The hallucinogenic world of tryptamines: an updated review.

Ara├║jo AM, Carvalho F, Bastos Mde L, Guedes de Pinho P, Carvalho M.

Arch Toxicol. 2015 Aug;89(8):1151-73. doi: 10.1007/s00204-015-1513-x. Epub 2015 Apr 16. Review.

PMID:
25877327
8.

An analysis of the synthetic tryptamines AMT and 5-MeO-DALT: emerging 'Novel Psychoactive Drugs'.

Arunotayanun W, Dalley JW, Huang XP, Setola V, Treble R, Iversen L, Roth BL, Gibbons S.

Bioorg Med Chem Lett. 2013 Jun 1;23(11):3411-5. doi: 10.1016/j.bmcl.2013.03.066. Epub 2013 Mar 28.

PMID:
23602445
9.

Metabolism of the tryptamine-derived new psychoactive substances 5-MeO-2-Me-DALT, 5-MeO-2-Me-ALCHT, and 5-MeO-2-Me-DIPT and their detectability in urine studied by GC-MS, LC-MSn , and LC-HR-MS/MS.

Caspar AT, Gaab JB, Michely JA, Brandt SD, Meyer MR, Maurer HH.

Drug Test Anal. 2017 Mar 24. doi: 10.1002/dta.2197. [Epub ahead of print]

PMID:
28342193
10.

Deaths associated with new designer drug 5-IT.

Seetohul LN, Maskell PD, De Paoli G, Pounder DJ.

BMJ. 2012 Aug 24;345:e5625. doi: 10.1136/bmj.e5625. No abstract available.

PMID:
22923530
11.

Clinical toxicology of newer recreational drugs.

Hill SL, Thomas SH.

Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Review. Erratum in: Clin Toxicol (Phila). 2011 Nov;49(9):880.

PMID:
21970769
12.

Designer drugs on the internet: a phenomenon out-of-control? the emergence of hallucinogenic drug Bromo-Dragonfly.

Corazza O, Schifano F, Farre M, Deluca P, Davey Z, Torrens M, Demetrovics Z, Di Furia L, Flesland L, Siemann H, Skutle A, Van Der Kreeft P, Scherbaum N.

Curr Clin Pharmacol. 2011 May;6(2):125-9. Review.

PMID:
21592070
13.

Combined intoxication with methylone and 5-MeO-MIPT.

Shimizu E, Watanabe H, Kojima T, Hagiwara H, Fujisaki M, Miyatake R, Hashimoto K, Iyo M.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):288-91. Epub 2006 Jul 28.

PMID:
16876302
14.

In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.

Nonaka R, Nagai F, Ogata A, Satoh K.

Biol Pharm Bull. 2007 Dec;30(12):2328-33.

15.

Intoxication delirium following use of synthetic cathinone derivatives.

Penders TM, Gestring RE, Vilensky DA.

Am J Drug Alcohol Abuse. 2012 Nov;38(6):616-7. doi: 10.3109/00952990.2012.694535. Epub 2012 Jul 11.

PMID:
22783894
16.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German CL, Fleckenstein AE, Hanson GR.

Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2. Review.

17.

"Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use.

Kasick DP, McKnight CA, Klisovic E.

Am J Drug Alcohol Abuse. 2012 Mar;38(2):176-80. doi: 10.3109/00952990.2011.643999. Epub 2012 Jan 5.

PMID:
22221190
18.
19.

'Legal highs'--novel and emerging psychoactive drugs: a chemical overview for the toxicologist.

Gibbons S.

Clin Toxicol (Phila). 2012 Jan;50(1):15-24. doi: 10.3109/15563650.2011.645952. Review.

PMID:
22248120
20.

Acute confusional state after designer tryptamine abuse.

Itokawa M, Iwata K, Takahashi M, Sugihara G, Sasaki T, Abe Y, Uno M, Hobo M, Jitoku D, Inoue K, Arai M, Yasuda I, Shintani M.

Psychiatry Clin Neurosci. 2007 Apr;61(2):196-9.

Supplemental Content

Support Center